Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer. [electronic resource]
Producer: 20190419Description: 408-412 p. digitalISSN:- 2005-9256
- Acrylamides
- Aniline Compounds
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Drug Resistance, Neoplasm
- ErbB Receptors -- genetics
- Female
- Gene Frequency
- Humans
- Lung Neoplasms -- drug therapy
- Middle Aged
- Mutation
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Republic of Korea
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.